|
|
||||||||
Papers In Press, published online ahead of print September 21, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inserm UMR505 and Université Pierre et Marie Curie, Centre de Recherche des Cordeliers, Paris 75006
Corresponding Author: athina.kalopissis-u505{at}bhdc.jussieu.fr
Postprandial hypertriglyceridemia and low plasma HDL levels that are principal features of the metabolic syndrome, are displayed by transgenic mice expressing human apolipoprotein A-II (hapo A-II). In these mice hypertriglyceridemia results from inhibition of lipoprotein lipase and hepatic lipase activities by hapo A-II carried on VLDL. This study aimed to determine whether the association of hapo A-II with triglyceride-rich lipoproteins (TRL) is sufficient to impair their catabolism. To measure plasma TRL residence time, intestinal TRL production was induced by a radioactive oral lipid bolus. Radioactive and total triglyceride (TG) were rapidly cleared in control mice but accumulated in plasma of transgenic mice, in relation to hapo A-II concentration. Similar plasma TG accumulations were measured in transgenic mice with or without endogenous apo A-II expression. Human apo A-II (synthesized in liver) was detected in chylomicrons (produced by intestine). The association of hapo A-II with TRL in plasma was further confirmed by the absence of hapo A-II in chylomicrons and VLDL of transgenic mice injected with Triton WR 1339, which prevents apolipoprotein exchanges. We show that the association of hapo A-II with TRL occurs in the circulation and induces postprandial hypertriglyceridemia.
Revised on September 12, 2006
Accepted on September 20, 2006
Human apolipoprotein A-II induces hypertriglyceridemia in transgenic mice by associating with triglyceride-rich lipoproteins in plasma and impairing their catabolism
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. W. Castellani, C. N. Nguyen, S. Charugundla, M. M. Weinstein, C. X. Doan, W. S. Blaner, N. Wongsiriroj, and A. J. Lusis Apolipoprotein AII Is a Regulator of Very Low Density Lipoprotein Metabolism and Insulin Resistance J. Biol. Chem., April 25, 2008; 283(17): 11633 - 11644. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hsueh, E. D. Abel, J. L. Breslow, N. Maeda, R. C. Davis, E. A. Fisher, H. Dansky, D. A. McClain, R. McIndoe, M. K. Wassef, et al. Recipes for Creating Animal Models of Diabetic Cardiovascular Disease Circ. Res., May 25, 2007; 100(10): 1415 - 1427. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |